CSL、イリノイ州の血漿療法製剤製造施設の拡張を発表
Thursday, March 12, 2026
2 min read
正規ソースAustralia
Standard Coverage40%
変更点
CSLは、イリノイ州カンカキーの血漿療法製剤製造施設を拡張するため、15億ドルの投資を発表した。この拡張により、少なくとも300人の新規雇用が創出される。
Key Figures
$1.5 billion investmentCSL's investment to expand its Illinois plasma therapy manufacturing facility.
at least 300 new jobsNumber of new jobs expected from the facility expansion.
Source Report
CSL announced a $1.5 billion investment to expand its plasma therapy manufacturing facility in Kankakee, Illinois, which is expected to create at least 300 new jobs.
Sigvera Intelligence
Industry Context
Healthtech & Biotech
Where this signal fits in the broader landscape.
110 業界シグナルExpansion
Company Activityすべて見る
Source Verification
Verified from official source
Publisher—
公開日Mar 12, 2026
ソース分類Verified Canonical
シグナルタイムライン
初回報道Mar 12, 2026
インデックスMar 12, 2026
公開Mar 12, 2026
https://newsroom.csl.com/2026-03-09-CSL-announces-expansion-of-Illinois-plasma-therapy-manufacturing-facility
Read Full Source信頼度:88%
Get cross-language signal intelligence
Get curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
My Notes
Sign in to save notes on signals.
ログイン